P53, encoded by the tumor suppressor gene TP53, is one of the most important tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53–MDM2 negative feedback loop. Abnormal p53 can be observed in almost all tumors, mainly including p53 mutation and functional inactivation. Blocking MDM2 to restore p53 function is a hotspot in the development of anticancer candidates. Till now, nine MDM2 inhibitors with different structural types have entered clinical trials. However, no MDM2 inhibitor has been approved for clinical application. This review focused on the discovery, structural modification, preclinical and clinical research of the above compounds from the perspective of medicinal chemistry. Based on this, the possible defects in MDM2 inhibitors in clinical development were analyzed to suggest that the multitarget strategy or targeted degradation strategy based on MDM2 has the potential to reduce the dose-dependent hematological toxicity of MDM2 inhibitors and improve their anti-tumor activity, providing certain guidance for the development of agents targeting the p53–MDM2 interaction.

Ferroptosis is a newly discovered way of programmed cell death, mainly caused by the accumulation of iron-dependent lipid peroxides in cells, which is morphologically, biochemically and genetically different from the previously reported apoptosis, necrosis and autophagy. Studies have found that ferroptosis plays a key role in the occurrence and development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and vascular dementia, which suggest that ferroptosis may be involved in regulating the progression of neurodegenerative diseases. At present, on the underlying mechanism of ferroptosis in neurodegenerative diseases is still unclear, and relevant research is urgently needed to clarify the regulatory mechanism and provide the possibility for the development of agents targeting ferroptosis. This review focused on the regulatory mechanism of ferroptosis and its various effects in neurodegenerative diseases, in order to provide reference for the research on ferroptosis in neurodegenerative diseases.

Introduction: The current field of research on the impact of COVID-19 on mental health was mostly limited to the evaluation of the first round of the epidemic, few reports focused on the impact of the re-emergence of COVID-19. This study aimed to investigate the mental health literacy and status of residents during the re-outbreak of COVID-19 in China.Methods: The basic information sheet, health literacy survey scale, physical health questionnaire-9 (PHQ-9), generalized anxiety disorder-7 (GAD-7), insomnia severity index (ISI), and Alzheimer dementia 8 (AD8) were applied to evaluate the mental health literacy, mental health status and elderly cognitive function, and χ2 test was applied for analysis of the difference between different groups.Results: A total of 2,306 participants were involved in this study, of which 734 people completed the mental health literacy survey. The qualified rate of mental health literacy was 6.4%. The difference is statistically significant. A total of 1,015 people completed the survey of mental health status, the prevalence of depressive symptoms was 8.87%, the monthly income of different families (χ2 = 13.96, P = 0.01), the self-assessed health status (χ2 = 128.56, P < 0.05), the presence or absence of chronic diseases (χ2 = 4.78, P = 0.03), among all which the difference was statistically significant; the prevalence of anxiety symptoms was 3.84%, different regions (χ2 = 12.26, P < 0.05), occupations (χ2 = 11.65, P < 0.05), household monthly income (χ2 = 12.65, P = 0.01), self-rated health status (χ2 = 151.11, P < 0.05), and chronic diseases (χ2 = 7.77, P = 0.01), among all which the differences were statistically significant. The prevalence of insomnia symptoms was 7.98%, different age (χ2 = 18.45, P < 0.05), region (χ2 = 5.11, P = 0.02), monthly household income (χ2 = 12.68 P = 0.01), and self-assessed health status (χ2 = 91.71, P < 0.05), in which there was a statistically significant difference between those with or without chronic diseases (χ2 = 3 3.25, P < 0.05). A total of 557 elderly people over 65 years old completed the cognitive dysfunction screening, in which the prevalence of cognitive dysfunction was 17.41%, and the difference was statistically significant at the different self-assessed health status (χ2 = 96.24, P < 0.05) and with or without chronic diseases (χ2 = 107.09, P < 0.05).Conclusion: The mental health literacy and status of residents have not improved significantly during the second outbreak of the epidemic, indicating that under the normalization of epidemic prevention and control, more attention should be paid to the mental health of residents, and targeted health education and psychological intervention should be carried out to avoid relative adverse events.

Objective: A systematic review and meta-analysis was performed to evaluate the prevalence of suicide ideation among HIV/AIDS patients in China.Methods: Systematic search of CNKI, Wanfang, China biology medicine database, Weipu, EMBASE, Web of science and PubMed for studies related to the suicide ideation of HIV/AIDS patients. The incidence of suicide ideation of HIV / AIDS patients in China was investigated by meta-analysis.Results: A total of 16 studies were included (n = 6,174). The incidence of suicidal ideation in HIV/AIDS patients was 30.6% (95%CI: 21.4–39.9%). The results of subgroup analysis showed that the incidence of suicidal ideation in male was 36.1%, which was higher than that in female (32.8%), homosexual patients (39.7%) higher than heterosexual patients (27.1%), 2013–2021 survey (35.2%) higher than 2003–2012 survey (26.5%), the unmarried patients (39.6%) were higher than the married patients (34.5%), the patients diagnosed >1 year (28.4%) were higher than the patients diagnosed 400 cells/ul group (19.8%).Conclusion: The incidence of suicide ideation in HIV/AIDS patients in China is relatively high.